Pancreatic Cancer Research

ResearcherRush University Medical CenterNo recent work listed

Andrew Armstrong

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers

Papers 3

  1. Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. Co-author DOI 10.1007/s11010-022-04377-5↗
  2. Correction to: Novel role of the Mu‑opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. Co-author DOI 10.1007/s11010-022-04400-9↗
  3. Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/biomedicines9070705↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Usman Barlass · 3 shared papers, 2021–2022 · strength 0.54
  2. Muhammad R. Haque · 3 shared papers, 2021–2022 · strength 0.54
  3. Faraz Bishehsari · 3 shared papers, 2021–2022 · strength 0.54
  4. Ajaypal Singh · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.